Velosulin Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

velosulin

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Semglee Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

semglee

viatris limited - insulina glargine - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sentejn u aktar.

Truvelog Mix 30 Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

truvelog mix 30

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - truvelog mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.

Levemir Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

levemir

novo nordisk a/s - insulin detemir - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sena u aktar.

NovoMix Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

novomix

novo nordisk a/s - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

NovoRapid Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

novorapid

novo nordisk a/s - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - novorapid huwa indikat għat-trattament tad-dijabete mellitus f'adulti, adoloxxenti u tfal ta 'sena u aktar.

Ryzodeg Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

ryzodeg

novo nordisk a/s - insulina aspart, l-insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal mill-età ta 'sentejn.

Suliqua Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

suliqua

sanofi winthrop industrie - l-insulina glargine, lixisenatide - diabetes mellitus, tip 2 - drogi użati fid-dijabete - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.

Tresiba Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

tresiba

novo nordisk a/s - insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus fl-adulti.

Kirsty (previously Kixelle) Avrupa Birliği - Maltaca - EMA (European Medicines Agency)

kirsty (previously kixelle)

biosimilar collaborations ireland limited - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.